US Stock MarketDetailed Quotes

PSTX Poseida Therapeutics

Watchlist

9.310
-0.020-0.21%

Close Nov 29 13:00 ET

9.300
-0.010-0.11%

Post 17:01 ET

907.40MMarket Cap-14777P/E (TTM)

Poseida Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-221.63%-9.59M

215.44%38.45M

60.18%-15.14M

-244.27%-92.17M

-1,296.17%-28.74M

-87.25%7.89M

16.17%-33.31M

25.95%-38.01M

73.89%-26.77M

-71.64%2.4M

Net income from continuing operations

163.68%20.24M

-14.26%-31.37M

37.51%-24.27M

-92.85%-123.43M

23.92%-25.35M

-145.13%-31.78M

36.20%-27.46M

33.09%-38.85M

48.79%-64M

-2,368.07%-33.32M

Operating gains losses

----

-99.14%3K

----

17,500.00%348K

2,960.00%143K

Depreciation and amortization

-8.66%1.32M

-4.39%1.35M

4.23%1.38M

8.55%5.61M

5.90%1.44M

6.96%1.44M

11.98%1.41M

9.69%1.32M

13.62%5.17M

14.54%1.36M

Other non cash items

-16.02%3.74M

29.06%-1.36M

17.24%-1.63M

-4.27%808K

-65.79%233K

176.44%4.46M

14.61%-1.92M

-123.86%-1.97M

32.08%844K

339.35%681K

Change In working capital

-188.52%-34.4M

675.00%62.2M

166.76%4M

2.67%14.08M

-125.88%-7.96M

566.69%38.86M

-843.16%-10.82M

20.91%-6M

-32.00%13.72M

45.93%30.77M

-Change in receivables

-171.85%-2.32M

88.47%-400K

-564.00%-3.02M

100.85%77K

-101.15%-338K

108.46%3.23M

-1,394.83%-3.47M

--650K

---9.09M

--29.38M

-Change in prepaid assets

31.41%-1.11M

37.93%1.8M

-144.90%-854K

213.63%1.57M

-104.54%-31K

-34.14%-1.61M

-22.51%1.31M

385.16%1.9M

118.79%499K

221.96%683K

-Change in payables and accrued expense

-37.41%1.52M

131.97%4.38M

10.11%-5.92M

212.96%6.04M

381.89%8.3M

341.57%2.44M

6,196.67%1.89M

-8.06%-6.59M

-180.58%-5.35M

-69.57%1.72M

-Change in other current assets

34.66%1.08M

11.35%893K

-0.68%871K

-36.01%3.33M

-15.17%850K

-39.75%805K

-34.48%802K

-46.78%877K

-5.91%5.21M

-67.32%1M

-Change in other current liabilities

-14.19%-1.04M

-14.08%-1.01M

-2.99%-963K

24.38%-3.67M

11.27%-937K

34.03%-909K

35.88%-888K

9.49%-935K

-55.86%-4.85M

-24.97%-1.06M

-Change in other working capital

-193.22%-32.54M

640.65%56.54M

828.82%13.88M

-75.34%6.73M

-1,543.35%-15.81M

8.53%34.9M

-323.74%-10.46M

-32.75%-1.91M

98.34%27.3M

---962K

Cash from discontinued investing activities

Operating cash flow

-221.63%-9.59M

215.44%38.45M

60.18%-15.14M

-244.27%-92.17M

-1,296.17%-28.74M

-87.25%7.89M

16.17%-33.31M

25.95%-38.01M

73.89%-26.77M

-71.64%2.4M

Investing cash flow

Cash flow from continuing investing activities

158.53%27.65M

-242.09%-61.2M

643.67%24M

119.25%39.13M

155.55%47.71M

-31.68%-47.24M

153.29%43.07M

-494.21%-4.42M

-191.43%-203.33M

-43,946.15%-85.89M

Net PPE purchase and sale

18.25%-645K

13.94%-1.02M

83.42%-130K

21.63%-3.07M

-18.85%-309K

53.34%-789K

2.79%-1.18M

-5.52%-784K

-49.54%-3.91M

-33.33%-260K

Net investment purchase and sale

160.91%28.29M

-235.99%-60.18M

764.64%24.13M

121.16%42.2M

156.08%48.02M

-35.89%-46.45M

155.59%44.26M

---3.63M

-188.63%-199.42M

---85.63M

Cash from discontinued investing activities

Investing cash flow

158.53%27.65M

-242.09%-61.2M

643.67%24M

119.25%39.13M

155.55%47.71M

-31.68%-47.24M

153.29%43.07M

-494.21%-4.42M

-191.43%-203.33M

-43,946.15%-85.89M

Financing cash flow

Cash flow from continuing financing activities

-95.03%742K

-103.63%-43K

-84.66%16.13M

-80.30%14.94M

-95.94%1.19M

4,076.29%105.16M

-75.42%58K

Net issuance payments of debt

----

--0

----

--30M

--0

Net common stock issuance

--0

-79.62%15.35M

--0

-80.85%14.42M

--0

--928K

--75.3M

--0

Proceeds from stock option exercised by employees

41.60%742K

--0

-26.99%549K

-2.60%1.28M

--0

-2.78%524K

--0

10.43%752K

-47.97%1.31M

-75.42%58K

Net other financing activities

--0

-19.84%-592K

65.93%-494K

--0

65.93%-494K

---1.45M

--0

Cash from discontinued financing activities

Financing cash flow

-95.03%742K

--0

-103.63%-43K

-84.66%16.13M

--0

-80.30%14.94M

--0

-95.94%1.19M

4,076.29%105.16M

-75.42%58K

Net cash flow

Beginning cash position

-38.80%30.55M

32.76%53.3M

-45.35%44.47M

-60.56%81.38M

-84.53%25.5M

-20.73%49.91M

-78.12%40.14M

-60.56%81.38M

145.72%206.33M

-16.68%164.81M

Current changes in cash

177.00%18.8M

-332.95%-22.75M

121.40%8.83M

70.46%-36.91M

122.74%18.97M

-123.97%-24.41M

108.10%9.77M

-80.57%-41.23M

-202.12%-124.95M

-1,079.90%-83.43M

End cash Position

93.47%49.34M

-38.80%30.55M

32.76%53.3M

-45.35%44.47M

-84.53%25.5M

-20.73%49.91M

-78.12%40.14M

-60.56%81.38M

Free cash flow

-244.23%-10.24M

208.53%37.43M

60.65%-15.27M

-210.25%-95.23M

-1,455.72%-29.05M

-88.20%7.1M

15.77%-34.49M

25.50%-38.79M

70.81%-30.7M

-74.06%2.14M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-221.63%-9.59M	215.44%38.45M	60.18%-15.14M	-244.27%-92.17M	-1,296.17%-28.74M	-87.25%7.89M	16.17%-33.31M	25.95%-38.01M	73.89%-26.77M	-71.64%2.4M
Net income from continuing operations	163.68%20.24M	-14.26%-31.37M	37.51%-24.27M	-92.85%-123.43M	23.92%-25.35M	-145.13%-31.78M	36.20%-27.46M	33.09%-38.85M	48.79%-64M	-2,368.07%-33.32M
Operating gains losses	----	----	----	-99.14%3K	----	----	----	----	17,500.00%348K	2,960.00%143K
Depreciation and amortization	-8.66%1.32M	-4.39%1.35M	4.23%1.38M	8.55%5.61M	5.90%1.44M	6.96%1.44M	11.98%1.41M	9.69%1.32M	13.62%5.17M	14.54%1.36M
Other non cash items	-16.02%3.74M	29.06%-1.36M	17.24%-1.63M	-4.27%808K	-65.79%233K	176.44%4.46M	14.61%-1.92M	-123.86%-1.97M	32.08%844K	339.35%681K
Change In working capital	-188.52%-34.4M	675.00%62.2M	166.76%4M	2.67%14.08M	-125.88%-7.96M	566.69%38.86M	-843.16%-10.82M	20.91%-6M	-32.00%13.72M	45.93%30.77M
-Change in receivables	-171.85%-2.32M	88.47%-400K	-564.00%-3.02M	100.85%77K	-101.15%-338K	108.46%3.23M	-1,394.83%-3.47M	--650K	---9.09M	--29.38M
-Change in prepaid assets	31.41%-1.11M	37.93%1.8M	-144.90%-854K	213.63%1.57M	-104.54%-31K	-34.14%-1.61M	-22.51%1.31M	385.16%1.9M	118.79%499K	221.96%683K
-Change in payables and accrued expense	-37.41%1.52M	131.97%4.38M	10.11%-5.92M	212.96%6.04M	381.89%8.3M	341.57%2.44M	6,196.67%1.89M	-8.06%-6.59M	-180.58%-5.35M	-69.57%1.72M
-Change in other current assets	34.66%1.08M	11.35%893K	-0.68%871K	-36.01%3.33M	-15.17%850K	-39.75%805K	-34.48%802K	-46.78%877K	-5.91%5.21M	-67.32%1M
-Change in other current liabilities	-14.19%-1.04M	-14.08%-1.01M	-2.99%-963K	24.38%-3.67M	11.27%-937K	34.03%-909K	35.88%-888K	9.49%-935K	-55.86%-4.85M	-24.97%-1.06M
-Change in other working capital	-193.22%-32.54M	640.65%56.54M	828.82%13.88M	-75.34%6.73M	-1,543.35%-15.81M	8.53%34.9M	-323.74%-10.46M	-32.75%-1.91M	98.34%27.3M	---962K
Cash from discontinued investing activities
Operating cash flow	-221.63%-9.59M	215.44%38.45M	60.18%-15.14M	-244.27%-92.17M	-1,296.17%-28.74M	-87.25%7.89M	16.17%-33.31M	25.95%-38.01M	73.89%-26.77M	-71.64%2.4M
Investing cash flow
Cash flow from continuing investing activities	158.53%27.65M	-242.09%-61.2M	643.67%24M	119.25%39.13M	155.55%47.71M	-31.68%-47.24M	153.29%43.07M	-494.21%-4.42M	-191.43%-203.33M	-43,946.15%-85.89M
Net PPE purchase and sale	18.25%-645K	13.94%-1.02M	83.42%-130K	21.63%-3.07M	-18.85%-309K	53.34%-789K	2.79%-1.18M	-5.52%-784K	-49.54%-3.91M	-33.33%-260K
Net investment purchase and sale	160.91%28.29M	-235.99%-60.18M	764.64%24.13M	121.16%42.2M	156.08%48.02M	-35.89%-46.45M	155.59%44.26M	---3.63M	-188.63%-199.42M	---85.63M
Cash from discontinued investing activities
Investing cash flow	158.53%27.65M	-242.09%-61.2M	643.67%24M	119.25%39.13M	155.55%47.71M	-31.68%-47.24M	153.29%43.07M	-494.21%-4.42M	-191.43%-203.33M	-43,946.15%-85.89M
Financing cash flow
Cash flow from continuing financing activities	-95.03%742K	0	-103.63%-43K	-84.66%16.13M	0	-80.30%14.94M	0	-95.94%1.19M	4,076.29%105.16M	-75.42%58K
Net issuance payments of debt	----	----	----	--0	----	----	----	----	--30M	--0
Net common stock issuance	--0	--0	--0	-79.62%15.35M	--0	-80.85%14.42M	--0	--928K	--75.3M	--0
Proceeds from stock option exercised by employees	41.60%742K	--0	-26.99%549K	-2.60%1.28M	--0	-2.78%524K	--0	10.43%752K	-47.97%1.31M	-75.42%58K
Net other financing activities	--0	--0	-19.84%-592K	65.93%-494K	--0	--0	--0	65.93%-494K	---1.45M	--0
Cash from discontinued financing activities
Financing cash flow	-95.03%742K	--0	-103.63%-43K	-84.66%16.13M	--0	-80.30%14.94M	--0	-95.94%1.19M	4,076.29%105.16M	-75.42%58K
Net cash flow
Beginning cash position	-38.80%30.55M	32.76%53.3M	-45.35%44.47M	-60.56%81.38M	-84.53%25.5M	-20.73%49.91M	-78.12%40.14M	-60.56%81.38M	145.72%206.33M	-16.68%164.81M
Current changes in cash	177.00%18.8M	-332.95%-22.75M	121.40%8.83M	70.46%-36.91M	122.74%18.97M	-123.97%-24.41M	108.10%9.77M	-80.57%-41.23M	-202.12%-124.95M	-1,079.90%-83.43M
End cash Position	93.47%49.34M	-38.80%30.55M	32.76%53.3M	-45.35%44.47M	-45.35%44.47M	-84.53%25.5M	-20.73%49.91M	-78.12%40.14M	-60.56%81.38M	-60.56%81.38M
Free cash flow	-244.23%-10.24M	208.53%37.43M	60.65%-15.27M	-210.25%-95.23M	-1,455.72%-29.05M	-88.20%7.1M	15.77%-34.49M	25.50%-38.79M	70.81%-30.7M	-74.06%2.14M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data